Unique Ingredient Identifier 3SY5LH9PMK is listed as a ingredient substance
RN | 63-42-3 |
EC | 200-559-2 |
NCIT | C74579 |
RXCUI | 1307662 |
UNII 3SY5LH9PMK ANHYDROUS LACTOSE is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
BUCCAL | TABLET | 23.75 MG |
IM - IV | INJECTABLE | 2.5 % |
IM - IV | POWDER, FOR INJECTION SOLUTION | 2.5 % |
INHALATION | POWDER | 1.16 MG/1INH |
INTRACAVITARY | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 4.75 % |
INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 5.7 %W/V |
IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 2.5 % |
ORAL | CAPSULE | 402.5 MG |
ORAL | CAPSULE (IMMED./COMP. RELEASE) | 46.06 MG |
ORAL | CAPSULE, COATED, SOFT GELATIN | 71.91 MG |
ORAL | CAPSULE, DELAYED RELEASE | 40 MG |
ORAL | CAPSULE, ENTERIC COATED PELLETS | 117 MG |
ORAL | CAPSULE, EXTENDED RELEASE | 53.8 MG |
ORAL | CAPSULE, HARD GELATIN | 238.24 MG |
ORAL | CAPSULE, SUSTAINED ACTION | 300.8 MG |
ORAL | GRANULE | 433 MG |
ORAL | GRANULE, FOR RECONSTITUTION | 15.69 MG |
ORAL | POWDER, FOR ORAL SUSPENSION | 468.7 MG/5ML |
ORAL | TABLET | 735.2 MG |
ORAL | TABLET (IMMED./COMP. RELEASE), COATED | 93.3 MG |
ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 204 MG |
ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL | 98.7 MG |
ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 108 MG |
ORAL | TABLET, CHEWABLE | 475.5 MG |
ORAL | TABLET, COATED | 144.19 MG |
ORAL | TABLET, DELAYED ACTION | 333 MG |
ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 90 MG |
ORAL | TABLET, DELAYED RELEASE | 420 MG |
ORAL | TABLET, EXTENDED RELEASE | 264.45 MG |
ORAL | TABLET, FILM COATED | 453.6 MG |
ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 48 MG |
ORAL | TABLET, ORALLY DISINTEGRATING | 25 MG |
ORAL | TABLET, SUSTAINED ACTION | 180.9 MG |
ORAL | TABLET, SUSTAINED ACTION, COATED | 130.7 MG |
ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 157.95 MG |
SUBLINGUAL | TABLET | 128 MG |
VAGINAL | TABLET | 605 MG |